Dr. Carlos R. Gonzalez, MD

Dr. Gonzalez practices at US Renal Care Baldwin Hills Dialysis in Beverly Hills, California.

Dr. Gonzalez's NPI, 1891722369, was assigned on June 28, 2006. Dr. Gonzalez graduated from University Auto De Baja California, Esc De Med in 1980. Dr. Gonzalez holds California license A43562.

Dr. Gonzalez's primary practice is US Renal Care Baldwin Hills Dialysis, at 8306 Wilshire Blvd, Beverly Hills, CA 90211 in Los Angeles County. The practice phone is (323) 293-4488.

Dr. Gonzalez's primary practice is US Renal Care Baldwin Hills Dialysis in Beverly Hills, California. Dr. Gonzalez is also affiliated with PIH Health Whittier Hospital. The medical group on file is Los Angeles County Nephrology Associates. Dmand AI also links Dr. Gonzalez to 4 more hospitals, 5 dialysis centers, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gonzalez practices, 12 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Gonzalez's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Gonzalez is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Gonzalez's licenses on file in 3 states: California, West Virginia and Pennsylvania.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances and parathyroid gland disorder among the conditions Dr. Gonzalez treats.

CMS data shows 1,556 Medicare services from Dr. Gonzalez across 12 procedure codes in 2024, for 514 Medicare patients. Medicare paid $202,688 for them.

CMS counts 514 Medicare patients who saw Dr. Gonzalez in 2024. The largest group is 65 to 74, with 178 patients. 75% of them have chronic kidney disease, and 75% have diabetes. 89% are also on Medicaid. Their average risk score is 6.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gonzalez's median patient age at 65, with 39% women.

In 2024, Dr. Gonzalez wrote 2,597 Medicare Part D claims for 237 patients. 44% of them were for generic drugs. CMS names the drug for 2,324 of them, across 42 drugs with 11 or more claims each, at $1,176,650 in total drug cost. In 2023, CMS named 2,107 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Gonzalez for performance year 2024, reported individually. Dr. Gonzalez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Gonzalez, published from 2013 to 2023. 2023 was the busiest year, with 2. Dr. Gonzalez's most frequent co-authors are Rajiv Agarwal, Glenn Matthew Chertow, MD and Pradip C.p. Chowdhury, MD.

CMS Open Payments shows 444 general payments to Dr. Gonzalez from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Akebia Therapeutics Inc paid the most, $2,522. It also lists 17 research payments totaling $2,052 from 2016 to 2019.

Dr. Gonzalez graduated from University Auto De Baja California, Esc De Med in 1980.

Dr. Gonzalez is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.